rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Tevogen Inc.

TVGN · Nasdaq

Health CareBiotechnologyNot moving yet

TVGN stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 3.1% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
16% -15 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$13K
Officials’ trades on record
0
Institutions holding
31 (+3)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

20 Apr – 19 Oct
17%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1.7M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months3
Buyers · sellers0 · 1
WhoDidSharesTraded
Neal FlomenbergOfficersold501at $6.4013 Mar 2026filed 17 Mar 2026
Neal FlomenbergOfficersold452at $7.2611 Mar 2026filed 17 Mar 2026
Neal FlomenbergOfficersold19at $7.7510 Mar 2026filed 17 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders31+3 on the quarter
New · exited16 · 13
Reported value$612K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202623,976$136K-9,272−27.9%
MORGAN STANLEYadded · filed 13 Aug 202618,809$106K+1,475+8.5%
AQR CAPITAL MANAGEMENT LLCnew · filed 14 Aug 202617,237$98K+17,237
GOLDMAN SACHS GROUP INCnew · filed 14 Aug 202614,163$80K+14,163
JANE STREET GROUP, LLCnew · filed 14 Aug 202611,175$63K+11,175
FMR LLCreduced · filed 13 Aug 20269,826$56K-331−3.3%
Russell Investments Group, Ltd.added · filed 6 Aug 20266,532$37K+726+12.5%
Tower Research Capital LLC (TRC)added · filed 11 Aug 20261,494$8,456+553+58.8%
UBS Group AGreduced · filed 13 Aug 20261,083$6,130-2,484−69.6%
VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026838$4,743-530−38.7%
31 Mar 2024 – 30 Jun 2026
62646Mar 24Sep 24Jun 25Dec 25Jun 26

Everyone who traded it

Kirti Desai Company insiderChief Financial Officer · last 14 Sep 20261 · 0
Ryan H. Saadi Company insiderChief Executive Officer · last 14 Sep 20261 · 1
Curtis L. Patton Company insiderDirector · last 11 Sep 20260 · 0
Jeffrey L. Feike Company insiderDirector · last 11 Sep 20260 · 0
Keow Lin Goh Company insiderDirector · last 11 Sep 20260 · 0
Susan M. Podlogar Company insiderDirector · last 11 Sep 20260 · 0
Victor J. Sordillo Company insiderDirector · last 11 Sep 20260 · 0
Neal Flomenberg Company insiderOfficer · last 13 Mar 20260 · 11
Sadiq Khan Company insiderChief Commercial Officer · last 27 Jun 20250 · 0
Corbin Erisa Opportunity Fund, Ltd. Company insider10% owner · last 17 Jul 20230 · 1
Semper Paratus Sponsor Llc Company insider10% owner · last 7 Jun 20231 · 1
Surendra K. Ajjarapu Company insiderCEO and Chairman · last 7 Jun 20230 · 0

Same industry

MRNA ModernaLeading+154%
ENTX Entera BioLeading+49%
XNCR XencorLeading+32%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Interest coverFY 2025 · to 31 Dec 2025133.63×
Share count trendFY 2025 · to 27 Mar 20263.6%
Cash and equivalentsFY 2025 · to 31 Dec 2025$0
Free cash flowFY 2025 · to 31 Dec 2025−$12.4M

Analyst forecasts

No analyst forecasts yet.